• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

IRRAS Strengthens Executive and Commercial Teams with Appointments of Karl-Matthias Moehlmann and Klemens Fölling
LA JOLLA, Calif., LAICHINGEN, Germany and STOCKHOLM, Sept. 13, 2017 -- (Healthcare Sales & Marketing Network) -- IRRAS, a commercial-stage medical technology company developing breakthrough devices for a broad range of intracranial bleeding applications a... Devices, Neurology, Personnel IRRAS, IRRAflow, stroke, intracranial pressure
Source: HSMN NewsFeed - September 13, 2017 Category: Pharmaceuticals Source Type: news

IRRAS Appoints Fredrik Alpsten as Chief Financial Officer and Deputy CEO
Mr. Alpsten will Lead the Development of IRRAS' Global Finance Strategies STOCKHOLM, Aug. 30, 2017 -- (Healthcare Sales & Marketing Network) -- IRRAS, a commercial-stage medical technology company developing breakthrough devices for a broad range of in... Devices, Neurosurgery, Monitoring, Personnel IRRAS, IRRAflow, stroke, ICP , intracranial bleeding
Source: HSMN NewsFeed - August 30, 2017 Category: Pharmaceuticals Source Type: news

In a Subanalysis, Eliquis(R) (apixaban) Reduced the Risk of Stroke and Demonstrated Fewer Major Bleeding Events versus Warfarin Consistently across Age Groups, Including Older Patients with Nonvalvular Atrial Fibrillation
Data from Phase 3 ARISTOTLE trial pre-specified subanalysis published in the European Heart Journal PRINCETON, N.J. & NEW YORK--(Healthcare Sales & Marketing Network)--Bristol-Myers Squibb Company (BMY) and Pfizer Inc. (PFE) today announced results of a... Biopharmaceuticals, CardiologyBristol-Myers Squibb, Pfizer, Eliquis, apixaban, atrial fibrillation, stroke
Source: HSMN NewsFeed - February 21, 2014 Category: Pharmaceuticals Source Type: news